Masahiro Natsuaki
Overview
Explore the profile of Masahiro Natsuaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Domei T, Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, et al.
Eur Heart J Cardiovasc Pharmacother
. 2025 Jan;
11(2):198-209.
PMID: 39863419
Aims: There were no previous studies comparing aspirin vs. P2Y12 inhibitor monotherapy following short dual antiplatelet therapy (DAPT) after complex percutaneous coronary intervention (PCI). Methods And Results: We conducted a...
2.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Oct;
11(1):34-44.
PMID: 39444052
Aims: Safety of aspirin-free strategy immediately after percutaneous coronary intervention (PCI) for cardiovascular events in patients with diabetes was unknown. Methods And Results: We conducted the prespecified subgroup analysis on...
3.
Watanabe H, Natsuaki M, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, et al.
Eur Heart J
. 2024 Aug;
45(47):5042-5054.
PMID: 39215959
Background And Aims: There was no previous trial comparing aspirin monotherapy with a P2Y12 inhibitor monotherapy following short dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents. Methods: In...
4.
Warisawa T, Sonoda S, Yamaji K, Amano T, Kohsaka S, Natsuaki M, et al.
Cardiovasc Interv Ther
. 2024 Jul;
39(4):386-402.
PMID: 39078544
Percutaneous coronary intervention for left main coronary artery disease (LM-PCI) represents a high-risk yet life-saving procedure that has evolved significantly over the years. This review outlines the current state-of-the-art practices...
5.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, et al.
J Am Heart Assoc
. 2024 Jul;
13(15):e034201.
PMID: 39056346
Background: The effects of aspirin-free strategy on bleeding and cardiovascular events in patients undergoing percutaneous coronary intervention with oral anticoagulation (OAC) have not been fully elucidated. Methods And Results: We...
6.
Watanabe H, Natsuaki M, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, et al.
Am J Cardiol
. 2024 Jul;
226:83-96.
PMID: 38972535
The current guidelines for acute coronary syndrome (ACS) discourage the use of anticoagulation after percutaneous coronary intervention (PCI) without specific indications, although the recommendation is not well supported by evidence....
7.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, et al.
JACC Cardiovasc Interv
. 2024 May;
17(9):1119-1130.
PMID: 38749592
Background: There was no study evaluating the effects of an aspirin-free strategy in patients undergoing complex percutaneous coronary intervention (PCI). Objectives: The authors aimed to evaluate the efficacy and safety...
8.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, et al.
J Cardiol
. 2024 May;
84(5):342-344.
PMID: 38735384
No abstract available.
9.
Yoshioka G, Tanaka A, Sonoda S, Kaneko T, Hongo H, Yokoi K, et al.
Cardiovasc Interv Ther
. 2024 Apr;
39(3):234-240.
PMID: 38615302
Despite advances in multidisciplinary acute care for myocardial infarction (MI), the clinical need to manage heart failure and elevated mortality risks in the remote phase of MI remains unmet. Various...
10.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Jan;
10(5):374-390.
PMID: 38285607
Background And Aims: High bleeding risk (HBR) and acute coronary syndrome (ACS) subtypes are critical in determining bleeding and cardiovascular event risk after percutaneous coronary intervention (PCI). Methods And Results:...